Semaglutide is a compounded GLP-1 medication and the active ingredient in Rybelsus, Ozempic and Wegovy
If you have any questions or would like to schedule an appointment, contact BODYWELLE today by calling (305) 877-5084.
We take a personalized approach to weight management, ensuring you achieve safe and sustainable results
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial
NOW AVAILABLE - SHIPPING DIRECT TO YOUR HOME The Ultimate Weight Loss Support for Men and Women Want to lose weight without restrictive dieting and giving up all the foods you love
New Safety Signal: Dysesthesia The TRIUMPH-4 Phase 3 trial revealed a previously unreported side effect called dysesthesia, which is an abnormal sensation of touch where normal sensory input feels unusual or uncomfortable